POD AD

Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of Moderate-to-Severe Atopic Dermatitis in Children?

Presented by the Atopic Dermatitis & Psoriasis Focused Study Group, and moderated by Dr. Minnelly Luu, Drs. Amy Paller, Elaine Siegfried, Jeff Yu, and A. Yasmine Kirkorian have a spirited discussion about the safety of JAK inhibitors in children, what interventions to try first, and the research that is still needed. Listen to learn more.

Minnelly Luu, MD

Moderator

Associate Professor of Clinical Dermatology, Keck School of Medicine of USC

Amy Paller, MD

Program Presenter

Chair of the Department of Dermatology, Walter J. Hamlin Professor of Dermatology and Professor of Pediatrics at Northwestern Fienberg School of Medicine

Elaine Siegfried, MD

Program Presenter

Professor of Pediatrics and Dermatology, St. Louis University School of Medicine

A. Yasmine Kirkorian

Program Presenter

Chief of Dermatology, Children’s National Hospital

JiaDe (Jeff) Yu, MD

Program Presenter

Assistant Professor of Adult and Pediatric Dermatology, Massachusetts General Hospital